409 results on '"Cimino, Patrick J."'
Search Results
2. HOXD12 defines an age-related aggressive subtype of oligodendroglioma
3. Papillary tumor of the pineal region: analysis of DNA methylation profiles and clinical outcomes in 76 cases
4. Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model
5. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion
6. ERK signaling promotes resistance to TRK kinase inhibition in NTRK fusion-driven glioma mouse models
7. Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT
8. Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome
9. Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival
10. Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1
11. Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions
12. Highly Multiplexed Spatially Resolved Proteomic and Transcriptional Profiling of the Glioblastoma Microenvironment Using Archived Formalin-Fixed Paraffin-Embedded Specimens
13. A single-cell based precision medicine approach using glioblastoma patient-specific models
14. Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain
15. The cell of origin dictates the temporal course of neurofibromatosis-1 ( Nf1 ) low-grade glioma formation
16. Single-cell CUT&Tag analysis of chromatin modifications in differentiation and tumor progression
17. ERK signaling promotes resistance to TRK kinase inhibition in NTRK fusion-driven glioma mouse models
18. Rapid Validation of Telepathology by an Academic Neuropathology Practice During the COVID-19 Pandemic
19. RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth
20. Machine learning modeling of genome-wide copy number alteration signatures reliably predicts IDH mutational status in adult diffuse glioma
21. Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome.
22. An anatomic transcriptional atlas of human glioblastoma
23. Whole gain of chromosome 19, not co-gain of chromosomes 19 and 20, characterizes a class of glioblastomas with more favorable outcomes
24. Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition
25. Validating MCM2 as a clinically relevant surrogate immunohistochemical marker for an aggressive meningioma molecular subtype
26. Clinicopathologic characteristics of metastatic esophageal carcinoma isolated to the pineal region: A case report and review of the literature
27. Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions
28. Targeted Next-Generation Sequencing in Molecular Subtyping of Lower-Grade Diffuse Gliomas: Application of the World Health Organization's 2016 Revised Criteria for Central Nervous System Tumors
29. Phenotypic characterization with somatic genome editing and gene transfer reveals the diverse oncogenicity of ependymoma fusion genes
30. A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways
31. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
32. IgG4-positive Cell Quantification Distinguishes Between Inflammatory and Noninflammatory Diseases of the Orbit
33. Orbital peripheral nerve sheath tumors
34. Mutational status of IDH1 in uveal melanoma
35. Intraoperative assessment of skull base tumors using stimulated Raman scattering microscopy
36. Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival
37. A scoping review of diffuse hemispheric glioma, H3 G34-mutant: Epigenetic and molecular profiles, clinicopathology, and treatment avenues.
38. Whole gain of chromosome 19, not co-gain of chromosomes 19 and 20, characterizes a class of glioblastomas with more favorable outcomes.
39. When a dermatopathologist encounters the ultra‐rare: A case series of superficial soft tissue/cutaneous myxopapillary ependymomas.
40. Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma.
41. Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma
42. Supplementary Figure S4 from Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2
43. Data from Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2
44. Supplementary Table S1 from Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2
45. Supplementary Data from Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals RB1 Signaling as a Novel Mediator and Biomarker
46. Malignant progression to anaplastic meningioma: Neuropathology, molecular pathology, and experimental models
47. A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel
48. Mouse Low-Grade Gliomas Contain Cancer Stem Cells with Unique Molecular and Functional Properties
49. Clival paragangliomas: a report of two cases involving the midline skull base and review of the literature
50. Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.